Susquehanna Fundamental Investments LLC Acquires New Stake in Mirion Technologies, Inc. (NYSE:MIR)

Susquehanna Fundamental Investments LLC purchased a new stake in Mirion Technologies, Inc. (NYSE:MIR - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 36,400 shares of the company's stock, valued at approximately $635,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of MIR. Barclays PLC boosted its stake in Mirion Technologies by 325.0% during the third quarter. Barclays PLC now owns 307,680 shares of the company's stock valued at $3,405,000 after buying an additional 235,288 shares in the last quarter. Artemis Investment Management LLP purchased a new position in shares of Mirion Technologies in the 4th quarter worth approximately $38,155,000. Simon Quick Advisors LLC lifted its holdings in shares of Mirion Technologies by 49.6% in the 4th quarter. Simon Quick Advisors LLC now owns 24,054 shares of the company's stock worth $420,000 after acquiring an additional 7,978 shares during the last quarter. Exchange Traded Concepts LLC lifted its position in Mirion Technologies by 291.4% during the fourth quarter. Exchange Traded Concepts LLC now owns 88,830 shares of the company's stock valued at $1,550,000 after purchasing an additional 66,132 shares during the period. Finally, KBC Group NV grew its position in Mirion Technologies by 39.2% in the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock worth $140,000 after acquiring an additional 2,254 shares in the last quarter. Hedge funds and other institutional investors own 78.51% of the company's stock.

Analyst Ratings Changes

MIR has been the topic of a number of recent research reports. B. Riley lowered their target price on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating on the stock in a research note on Wednesday, April 16th. Robert W. Baird cut their target price on Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating on the stock in a research report on Friday, April 4th. Finally, Citigroup cut their target price on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Four equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $18.75.

Mirion Technologies Trading Up 1.2 %

Shares of NYSE:MIR traded up $0.19 during midday trading on Thursday, reaching $16.29. The company's stock had a trading volume of 106,484 shares, compared to its average volume of 1,676,331. The business has a 50 day moving average price of $14.56 and a 200 day moving average price of $15.70. The firm has a market cap of $3.79 billion, a price-to-earnings ratio of -85.74 and a beta of 0.74. Mirion Technologies, Inc. has a 1 year low of $9.11 and a 1 year high of $18.81. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43.

Mirion Technologies (NYSE:MIR - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. Mirion Technologies had a positive return on equity of 4.78% and a negative net margin of 4.21%. The company had revenue of $202.00 million during the quarter, compared to the consensus estimate of $199.34 million. During the same period in the previous year, the firm posted $0.06 earnings per share. Mirion Technologies's quarterly revenue was up 4.9% compared to the same quarter last year. Research analysts forecast that Mirion Technologies, Inc. will post 0.39 EPS for the current year.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.